2024 annual financial data
InMed Pharmaceuticals 2024 Operating margin
Direct answer
Operating margin was -176.92%.
Operating income was -8,134,430 CAD and net income was -7,675,550 CAD.
Operating cash flow was -6,985,832 CAD.
Get free InMed Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,597,730 CAD
- Operating income
- -8,134,430 CAD
- Net income
- -7,675,550 CAD
- Operating cash flow
- -6,985,832 CAD